Courage Ventures

Courage Ventures has a website, LinkedIn, and Crunchbase footprint but limited disclosed thesis detail in the source data, and the name overlaps with multiple venture entities globally, including Courage Capital and Courage Ventures Fund associated with different geographies and stages. Without firm-specific verification, healthcare AI founders should treat Courage as a generalist early-stage fund unless the conversation with the team confirms healthcare positioning. Plausible check sizing for firms at this footprint is $250K to $1.5M at seed, often as a co-investor rather than lead. Founders best suited to Courage are those at seed with a clear lead committed and seeking additional capacity, particularly if there is a personal or referral connection to the partners. The firm is unlikely to be the right partner for deep biotech, FDA-regulated diagnostics or devices, or capital-intensive infrastructure plays where specialist healthcare capital is required. Healthcare AI founders building software-style products, like clinical workflow, revenue cycle automation, patient engagement, or applied AI for operational efficiency, are more likely to find a possible fit than therapeutics or hardware founders. Entry path runs through LinkedIn outreach to the partners and the firm’s website form. Before scheduling a pitch, founders should ask the firm directly about its three most recent healthcare investments and typical follow-on behavior, since the source data does not surface enough to confirm pattern-match. Honesty matters here: with this little public signal, Courage should be a B-tier outreach target unless a warm intro surfaces a real thesis fit, and founder time is better spent on disclosed-thesis healthcare investors first.